Consensus summary on the definition of asthma remission
Rohit Katial, Michael E. Wechsler, Praveen Akuthota, D. J. Jackson, Ian Pavord, Linda Rogers, Daniel J. Jackson, Josef S Smolen, Flavia Hoyte
Abstract
Striving for clinical remission in asthma is a new approach to treatment whose time has come. It is critical that a widely accepted definition of asthma clinical remission be developed that is agreed to be both practical and meaningful to clinicians, researchers, and patients. To advance this development process, National Jewish Health convened a panel of experts in the field for a 2-day virtual workshop to critically assess previously proposed definitions of remission in asthma and other immune-mediated diseases and the latest evidence from clinical studies of remission in patients with asthma treated with biologic therapies. After careful deliberation, we present the panel's definition of asthma clinical remission and identify unresolved issues that deserve further investigation and wider discussion among different stakeholder groups. This article is part of a supplement supported by an educational grant from AstraZeneca Pharmaceuticals. The content of this article was developed independently by National Jewish Health and the article authors.